What role does CYP2C19 play in Allergie?

CYP2C19 is a cytochrome P450 enzyme primarily involved in metabolizing drugs such as proton pump inhibitors (omeprazole) and clopidogrel. Regarding allergies, CYP2C19 does not play a direct pathophysiological role. However, genetic variants (e.g., *2, *3, *17) can affect the efficacy and tolerability of medications used in allergy treatment, such as certain antihistamines or corticosteroids. Some studies suggest associations between CYP2C19 polymorphisms and allergic conditions like asthma or atopic dermatitis, but the evidence is weak and inconsistent. Clinical relevance for allergy diagnosis or management is limited. A DNA test for CYP2C19 may provide insights into drug metabolism, but it does not replace a medical allergy evaluation. Its utility is confined to pharmacogenetics, not to understanding allergy causation.